Final Trades: ServiceNow, Vertex Pharmaceuticals and the IJR
Youtubeยท2025-10-02 17:31
Group 1 - ServiceNow stock has decreased by 14% year-to-date, indicating a potential investment opportunity as the company begins to monetize its AI tools [1] - Vertex has a strong drug profile and has recently entered positive territory for the year, which is significant as it removes the company from the tax loss harvesting category [2]